Molecular genetics of ovarian cancer

被引:0
作者
Andrew N. Shelling
William Foulkes
机构
[1] National Women’s Hospital,Centre in Reproductive Medicine, Department of Obstetrics and Gynaecology
来源
Molecular Biotechnology | 2001年 / 19卷
关键词
Ovarian cancer; molecular genetics; gene identification; mutation screening;
D O I
暂无
中图分类号
学科分类号
摘要
This is a review of the approaches that can be used to analyze genetic changes in ovarian cancer. Traditional gene localization methods are discussed, followed by a section on gene identification techniques. Once a putative disease-associated gene has been cloned, mutations have to be identified and analyzed. There are numerous mutation detection methods, and the most common ones are outlined. In the penultimate section, the role of immunohistochemistry as a surrogate method for mutation analysis is considered. Finally, the possible use of functional assays is discussed. At present, it would appear that DNA chip technology for the detection of mutations, and microarray analysis of gene expression, are two important techniques likely to have a significant impact on the genetic analysis of ovarian cancer.
引用
收藏
页码:13 / 28
页数:15
相关论文
共 213 条
[1]  
Friend S. H.(1986)A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma Nature 323 643-646
[2]  
Bernards R.(1994)A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 Science 266 66-71
[3]  
Rogelj S.(1995)Identification of the breast cancer susceptibility gene BRCA2 Nature 378 789-792
[4]  
Miki Y.(1996)Mutation analysis in the BRCA2 gene in primary breast cancers Nature Genet. 13 245-247
[5]  
Swensen J.(1994)BRCA1 mutations in primary breast and ovarian carcinomas Science 266 120-122
[6]  
Shattuck-Eidens D.(1995)Somatic mutations in the BRCA1 gene in sporadic ovarian tumors Nature Genet. 9 439-443
[7]  
Wooster R.(1996)Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer Cancer Res. 56 3622-3625
[8]  
Bignell G.(1997)Association of BRCA1 with Rad51 in mitotic and meiotic cells Cell 88 265-275
[9]  
Lancaster J.(1993)p53 gene mutations and protein accumulation in human ovarian cancer Proc. Natl. Acad. Sci. USA 90 4961-4965
[10]  
Miki Y.(1995)c-erbB2 gene amplification and protein expression in ovarian epithelial tumors: evaluation of their respective prognostic significance by multivariate analysis Int. J. Cancer 64 146-151